Cite
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
MLA
Nyrop, Kirsten A., et al. “Congruence of Patient- and Clinician-Reported Toxicity in Women Receiving Chemotherapy for Early Breast Cancer.” Cancer (0008543X), vol. 126, no. 13, July 2020, pp. 3084–93. EBSCOhost, https://doi.org/10.1002/cncr.32898.
APA
Nyrop, K. A., Deal, A. M., Reeve, B. B., Basch, E., Chen, Y. T., Park, J. H., Shachar, S. S., Carey, L. A., Reeder, H. K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., Reinbolt, R. E., Speca, J. C., Lee, J. T., Wood, W. A., Muss, H. B., & Reeder-Hayes, K. E. (2020). Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer. Cancer (0008543X), 126(13), 3084–3093. https://doi.org/10.1002/cncr.32898
Chicago
Nyrop, Kirsten A., Allison M. Deal, Bryce B. Reeve, Ethan Basch, Yi Tang Chen, Ji Hye Park, Shlomit S. Shachar, et al. 2020. “Congruence of Patient- and Clinician-Reported Toxicity in Women Receiving Chemotherapy for Early Breast Cancer.” Cancer (0008543X) 126 (13): 3084–93. doi:10.1002/cncr.32898.